Current stage-Stage II Posts on Medivizor
Navigation Menu

Current stage-Stage II Posts on Medivizor

Cardiovascular effects of chemotherapy after colorectal cancer surgery

Posted by on Apr 3, 2020 in Colorectal cancer | 0 comments

In a nutshell This study investigated the cardiovascular effects of chemotherapy after colorectal cancer (CRC) surgery. Researchers suggested that this treatment increases the stiffness of blood vessels in patients with CRC. Some background Colorectal cancer is a major cause of cancer mortality. However, the mortality rate has decreased in the...

Read More

Adjuvant chemotherapy improves survival of patients with locally advanced rectal cancer

Posted by on Mar 20, 2020 in Colorectal cancer | 0 comments

In a nutshell This study investigated the role and optimal dose and duration of adjuvant (after surgery) chemotherapy (AC) in patients with locally advanced rectal cancer. Researchers suggested that this treatment was associated with improved survival in these patients. Some background Colorectal cancer is one of the most common cancers worldwide....

Read More

Benefits of therapy for early stage breast cancer

Posted by on Feb 29, 2020 in Breast cancer | 0 comments

In a nutshell This paper is a document that was developed at a breast cancer conference by a number of experts in the field. It outlines suggested treatment for early-stage breast cancer. The experts concluded that patients and doctors should work together and discuss the benefit of treating early-stage breast cancer in comparison with the potential...

Read More

Are abdominal infections a prognostic factor for recurrence after colorectal cancer surgery?

Posted by on Jan 26, 2020 in Colorectal cancer | 0 comments

In a nutshell This study investigated whether tummy infections (TIs) after surgery are associated with colorectal cancer outcomes. Researchers suggested that TIs might be associated with a shorter time until recurrence. Some background Colorectal cancer is a common cancer in the US affecting more than 145,000 people every year. Surgery is...

Read More

Surgery followed by chemotherapy improves the outcomes of patients with rectal cancer

Posted by on Oct 13, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness of surgery followed by chemotherapy without chemoradiotherapy (CRT) before surgery to treat rectal cancer. Researchers suggested that this treatment improves the outcomes of these patients.  Some background Colorectal cancer is the third most common cancer worldwide. The standard...

Read More

Is there a best duration of post-surgery chemotherapy in patients with colon cancer?

Posted by on Jul 28, 2019 in Colorectal cancer | 0 comments

In a nutshell This study compared a 3-month with a 6-month chemotherapy treatment after colon cancer surgery. Researchers suggested that the duration of the treatment should be chosen according to the patient condition. Some background Colorectal cancer is one of the most common cancers worldwide. Stage 2 and 3 colon cancer are common and curable...

Read More

Trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer

Posted by on Jul 14, 2019 in Breast cancer | 0 comments

In a nutshell This study wanted to find out which treatment was better before surgery for patients with HER2-positive breast cancer, trastuzumab emtansine (Kadcycla) plus pertuzumab (Perjeta), or a standard treatment. The study found that patients treated with trastuzumab emtansine plus pertuzumab (TEP) were more likely to have cancer...

Read More